Mission Creek Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $980K | Sell |
2,416
-513
| -18% | -$208K | 0.22% | 96 |
|
|
2025
Q1 | $1.46M | Sell |
2,929
-527
| -15% | -$262K | 0.35% | 79 |
|
|
2024
Q4 | $1.8M | Buy |
3,456
+43
| +1% | +$22.4K | 0.39% | 71 |
|
|
2024
Q3 | $2.11M | Buy |
3,413
+55
| +2% | +$34K | 0.49% | 61 |
|
|
2024
Q2 | $1.86M | Buy |
3,358
+1,504
| +81% | +$832K | 0.47% | 59 |
|
|
2024
Q1 | $1.08M | Buy |
1,854
+759
| +69% | +$441K | 0.28% | 99 |
|
|
2023
Q4 | $581K | Sell |
1,095
-5
| -0.5% | -$2.65K | 0.15% | 144 |
|
|
2023
Q3 | $557K | Sell |
1,100
-116
| -10% | -$58.7K | 0.19% | 140 |
|
|
2023
Q2 | $634K | Sell |
1,216
-6
| -0.5% | -$3.13K | 0.2% | 136 |
|
|
2023
Q1 | $704K | Hold |
1,222
| – | – | 0.24% | 123 |
|
|
2022
Q4 | $673K | Sell |
1,222
-66
| -5% | -$36.3K | 0.24% | 120 |
|
|
2022
Q3 | $653K | Sell |
1,288
-25
| -2% | -$12.7K | 0.25% | 117 |
|
|
2022
Q2 | $713K | Sell |
1,313
-20
| -2% | -$10.9K | 0.24% | 120 |
|
|
2022
Q1 | $787K | Sell |
1,333
-10
| -0.7% | -$5.9K | 0.21% | 132 |
|
|
2021
Q4 | $896K | Sell |
1,343
-102
| -7% | -$68.1K | 0.18% | 139 |
|
|
2021
Q3 | $826K | Sell |
1,445
-145
| -9% | -$82.9K | 0.15% | 139 |
|
|
2021
Q2 | $802K | Hold |
1,590
| – | – | 0.13% | 130 |
|
|
2021
Q1 | $726K | Sell |
1,590
-150
| -9% | -$68.5K | 0.11% | 130 |
|
|
2020
Q4 | $810K | Hold |
1,740
| – | – | 0.25% | 109 |
|
|
2020
Q3 | $768K | Hold |
1,740
| – | – | 0.3% | 97 |
|
|
2020
Q2 | $630K | Hold |
1,740
| – | – | 0.33% | 81 |
|
|
2020
Q1 | $493K | Buy |
1,740
+70
| +4% | +$19.8K | 0.26% | 88 |
|
|
2019
Q4 | $543K | Buy |
+1,670
| New | +$543K | 0.25% | 106 |
|